Principal Investigator for COVID-19 drug with FDA Emergency Use Authorization available to speak on limited government supply of drug and pending clinical trials

COVID-19 and Monoclonal Antibodies – Emergency Use Authorization for Bamlanivimab The FDA’s Emergency Use Authorization to treat high risk COVID-19 patients with the monoclonal antibody bamlanivimab will offer limited availability in Texas, where only 6,000 government doses are expected next…